French Innovation
Mechanical medical technology · Sophia Antipolis

Mechanical autonomy for pressure-assisted infusion.

PERFU+3 explores a power-independent approach to pressurising flexible infusion bags. The immediate priority is to demonstrate an integrated mechanical architecture that can be assessed and verified.

Mechanical principleBattery-free conceptUnder development
Conceptual visual of the PERFU+3 device: a white housing with a window showing a flexible infusion bag and its tubing
Battery-freein the concept under study
3 patent applicationsfiled in France

Conceptual visual, non-contractual · does not depict a validated prototype

Priority: integrated demonstratorMechanical proof pending
3 French patent applicationsFilings reported · No grant claimed
Qualified engineering partnershipsEngineering · Prototyping · Future transfer
Our rationale

Reducing technical dependencies in demanding environments.

Power supply, maintenance and logistics can become constraints. PERFU+3 investigates a mechanical approach whose operational robustness must still be demonstrated.

01 — AUTONOMY

Independent of external power

A concept designed to generate compression force using stored mechanical energy, without a battery or control software.

02 — SAFETY

Passive functions under study

Transmission, guidance and limiting functions are being investigated and must be verified physically.

03 — TRANSFER

Engineered for partnership

AXELYUM is organising a documented engineering baseline for collaboration with design engineers and, eventually, qualified manufacturers.

Perspective conceptual view of the PERFU+3 device with a flexible 500 mL infusion bag, two ports and connected tubing
Conceptual visual (computer-generated image), non-contractual. It depicts neither a validated prototype nor an available product.
The concept at a glance

One flexible bag, two separate lines.

The PERFU+3 concept houses a flexible infusion bag in a sliding housing, with a line to the patient and a drug-injection line kept clearly separate.

  • Drug-injection lineNot connected in the illustrated configuration.
  • Infusion line to the patientConnected: this is the line that feeds the infusion.
Understand the technology
Where we stand

A documented technology. Physical proof still to be established.

Our technical work focuses on resolving interfaces, force paths, guidance and passive safety functions before producing an integrated mechanical demonstrator.

Transparency note: no integrated prototype is claimed to have been validated at this stage. Functional targets are design requirements, not demonstrated performance.
View the roadmap
Development sequence
01

P3-L1 feasibility review

Mechanical assessment and identification of design gaps.

02

Integrated engineering

Interfaces, kinematics, guidance and safety functions.

03

Demonstrator and testing

Assembly, measurements, iteration and experimental evidence.

Potential contexts

Real needs. Applications to assess.

These settings are not claimed clinical indications or validated uses; they guide feasibility discussions.

01

Emergency and pre-hospital

Potential deployment away from standard infrastructure.

02

Medical transport

Operational continuity in mobile settings.

03

Remote care

Power, servicing and supply-chain constraints.

04

Disaster response

Deployment when usual infrastructure is disrupted.

05

Civil protection

Resilience and emergency-response scenarios.

06

Operational healthcare

To be assessed with competent stakeholders, with no qualification claimed.

Engineering & partnerships

We seek partners who can turn an architecture into evidence.

Our immediate need is for mechanical engineering firms and prototyping teams able to conduct an independent review, integrate the mechanism and prepare physical tests.

Mechanical engineering

Kinematics, force-path analysis, tolerances and assembly.

Prototyping

Build, integration and iterative demonstrator work.

Medical-device expertise

Risk analysis, requirements and verification strategy.

Future industrial partner

DFM, quality, regulatory, manufacturing and market access.

AXELYUM MEDTECH

Mature the technology and prepare its transfer.

AXELYUM MEDTECH is a French R&D company dedicated to mechanical medical technologies. It structures technical and intellectual-property assets to enable future collaboration with qualified industrial partners.

Our collaboration model →
Company identity

AXELYUM MEDTECH SASU

Sophia Antipolis · Valbonne · France

2026Founded
3French patent applications filed
P3-L1Feasibility assessment

No issued-patent, certification or clinical-validation claim.

Professional dialogue

Discuss a PERFU+3 feasibility review?

A non-confidential scoping brief is available upon request. Detailed material is selectively shared, including under NDA where appropriate.

Contact us ↗